189 related articles for article (PubMed ID: 21625859)
1. Association between type 2 diabetes and CDKN2A/B: a meta-analysis study.
Bao XY; Xie C; Yang MS
Mol Biol Rep; 2012 Feb; 39(2):1609-16. PubMed ID: 21625859
[TBL] [Abstract][Full Text] [Related]
2. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis.
Peng F; Hu D; Gu C; Li X; Li Y; Jia N; Chu S; Lin J; Niu W
Gene; 2013 Dec; 531(2):435-43. PubMed ID: 24012816
[TBL] [Abstract][Full Text] [Related]
3. Association between type 2 diabetes and rs10811661 polymorphism upstream of CDKN2A/B: a meta-analysis.
Li H; Tang X; Liu Q; Wang Y
Acta Diabetol; 2013 Oct; 50(5):657-62. PubMed ID: 22623142
[TBL] [Abstract][Full Text] [Related]
4. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
Wu Y; Li H; Loos RJ; Yu Z; Ye X; Chen L; Pan A; Hu FB; Lin X
Diabetes; 2008 Oct; 57(10):2834-42. PubMed ID: 18633108
[TBL] [Abstract][Full Text] [Related]
5. Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.
Duesing K; Fatemifar G; Charpentier G; Marre M; Tichet J; Hercberg S; Balkau B; Froguel P; Gibson F
Diabetologia; 2008 May; 51(5):821-6. PubMed ID: 18368387
[TBL] [Abstract][Full Text] [Related]
6. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
Grarup N; Rose CS; Andersson EA; Andersen G; Nielsen AL; Albrechtsen A; Clausen JO; Rasmussen SS; Jørgensen T; Sandbaek A; Lauritzen T; Schmitz O; Hansen T; Pedersen O
Diabetes; 2007 Dec; 56(12):3105-11. PubMed ID: 17827400
[TBL] [Abstract][Full Text] [Related]
7. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort.
Wen J; Rönn T; Olsson A; Yang Z; Lu B; Du Y; Groop L; Ling C; Hu R
PLoS One; 2010 Feb; 5(2):e9153. PubMed ID: 20161779
[TBL] [Abstract][Full Text] [Related]
8.
Kong Y; Sharma RB; Ly S; Stamateris RE; Jesdale WM; Alonso LC
Diabetes; 2018 May; 67(5):872-884. PubMed ID: 29432124
[TBL] [Abstract][Full Text] [Related]
9. Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population.
Han X; Luo Y; Ren Q; Zhang X; Wang F; Sun X; Zhou X; Ji L
BMC Med Genet; 2010 May; 11():81. PubMed ID: 20509872
[TBL] [Abstract][Full Text] [Related]
10. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
Lee YH; Kang ES; Kim SH; Han SJ; Kim CH; Kim HJ; Ahn CW; Cha BS; Nam M; Nam CM; Lee HC
J Hum Genet; 2008; 53(11-12):991-998. PubMed ID: 18991055
[TBL] [Abstract][Full Text] [Related]
11. Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations.
Zhang H; Mao JS; Hu WF
Med Sci Monit; 2019 Feb; 25():1307-1313. PubMed ID: 30774116
[TBL] [Abstract][Full Text] [Related]
12. Tagging rs10811661 variant at CDKN2A/2B locus is not associated with type 2 diabetes mellitus in Czech population.
Hubáček JA; Neškudla T; Klementová M; Adámková V; Pelikánová T
Folia Biol (Praha); 2013; 59(4):168-71. PubMed ID: 24093775
[TBL] [Abstract][Full Text] [Related]
13. Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B.
Hribal ML; Presta I; Procopio T; Marini MA; Stančáková A; Kuusisto J; Andreozzi F; Hammarstedt A; Jansson PA; Grarup N; Hansen T; Walker M; Stefan N; Fritsche A; Häring HU; Pedersen O; Smith U; Laakso M; Sesti G;
Diabetologia; 2011 Apr; 54(4):795-802. PubMed ID: 21234743
[TBL] [Abstract][Full Text] [Related]
14. TOX and CDKN2A/B Gene Polymorphisms Are Associated with Type 2 Diabetes in Han Chinese.
Wei F; Cai C; Feng S; Lv J; Li S; Chang B; Zhang H; Shi W; Han H; Ling C; Yu P; Chen Y; Sun N; Tian J; Jiao H; Yang F; Li M; Wang Y; Zou L; Su L; Li J; Li R; Qiu H; Shi J; Liu S; Chang M; Lin J; Chen L; Li WD
Sci Rep; 2015 Jul; 5():11900. PubMed ID: 26139146
[TBL] [Abstract][Full Text] [Related]
15. Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.
Noury AE; Azmy O; Alsharnoubi J; Salama S; Okasha A; Gouda W
BMC Res Notes; 2018 Mar; 11(1):181. PubMed ID: 29544538
[TBL] [Abstract][Full Text] [Related]
16. FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: a meta-analysis.
Guo F; Long W; Zhou W; Zhang B; Liu J; Yu B
Arch Gynecol Obstet; 2018 Oct; 298(4):705-715. PubMed ID: 30074065
[TBL] [Abstract][Full Text] [Related]
17. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians.
Ng MC; Park KS; Oh B; Tam CH; Cho YM; Shin HD; Lam VK; Ma RC; So WY; Cho YS; Kim HL; Lee HK; Chan JC; Cho NH
Diabetes; 2008 Aug; 57(8):2226-33. PubMed ID: 18469204
[TBL] [Abstract][Full Text] [Related]
18. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants.
Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X
Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493
[TBL] [Abstract][Full Text] [Related]
19. Interaction between a variant of CDKN2A/B-gene with lifestyle factors in determining dyslipidemia and estimated cardiovascular risk: A step toward personalized nutrition.
Mehramiz M; Ghasemi F; Esmaily H; Tayefi M; Hassanian SM; Sadeghzade M; Sadabadi F; Moohebati M; Azarpazhooh MR; Parizadeh SMR; Heidari-Bakavoli A; Safarian M; Nematy M; Ebrahimi M; Ryzhikov M; Ferns GA; Ghayour-Mobarhan M; Avan A
Clin Nutr; 2018 Feb; 37(1):254-261. PubMed ID: 28065479
[TBL] [Abstract][Full Text] [Related]
20. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.
Tabara Y; Osawa H; Kawamoto R; Onuma H; Shimizu I; Miki T; Kohara K; Makino H
Diabetes; 2009 Feb; 58(2):493-8. PubMed ID: 19033397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
